Alector LLC

Eric Brown

Arnon Rosenthal

Tina Schwabe

Seung-Joo Lee

Robert Pejchal

Herve Rhinn

Ilaria Tassi

Angie Grace Yee

Philip Ling Kong

Nels P Nielson

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, antibody fragments, etc., that specifically bind a TMEM106B polypeptide, e.g., a mammalian TMEM106B or human TMEM106B, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-TMEM106B antibodies and methods of use thereof

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 or human TREM2, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-TREM2 antibodies and methods of use thereof

Growing community of inventors

Colma, CA, United States of America

Eric Brown